• Your blueprint for earlier answers, clearer decisions, and a longer, healthier life.

    VitalRisk™ analyzes the unique combination of your genetics, key biomarkers, and evidence-based clinical risk factors to build a personalized risk profile for major conditions, including heart disease, diabetes, stroke, certain cancers, and neurodegenerative diseases.

    What You Get

    • Whole-Genome Sequencing (WGS): An evaluation of your DNA—the body’s instruction manual.

    • Personalized Polygenic Risk Scores (PRS): Advanced calculations that measure how your genes influence your risk for common diseases.

    • AI-Enhanced Clinical Modeling: We combine genetic risk with biomarker trends, family history, and other clinical thresholds to create an individualized risk gradient.

    • Action-Ready Insights: Your report highlights what’s relevant for you, including recommended lifestyle modifications, optional follow-up testing, and targeted prevention strategies discussed with your physician.

    Why It Matters

    Most chronic diseases develop silently for years. VitalRisk™ helps identify hidden susceptibility early—before symptoms appear—so you and your care team can take meaningful steps to prevent disease, slow progression, or personalize your long-term health strategy.

    Who It’s For

    Anyone who wants to move beyond reactive medicine and take a proactive, personalized approach to their health—especially those with family histories of heart disease, diabetes, cancer, or Alzheimer’s, or anyone wanting a deeper understanding of their body’s long-term roadmap.

  • A precision-medicine tool that elevates care, improves early detection, and strengthens the provider–patient relationship.

    The VitalRisk™ assessment tool is a comprehensive, whole-genome–based disease-risk evaluation designed to integrate seamlessly into your existing clinical workflow. Using whole-genome sequencing, polygenic risk scoring, and evidence-based clinical modeling, VitalRisk™ helps identify high-risk patients long before traditional markers or symptoms emerge—supporting proactive, data-driven care.

    Why Providers Use VitalRisk™

    • Earlier Detection & Better Stratification
      VitalRisk™ identifies elevated genetic susceptibility to conditions like heart disease, diabetes, stroke, select cancers, and neurodegenerative disorders—allowing you to risk-stratify patients with greater precision.

    • Actionable, Clinically Interpretable Reports
      Each patient report synthesizes genomic findings, PRS values, biomarker inputs, and clinical thresholds to present clear, prioritized risk categories. Reports are built to support clinical decision-making, not overwhelm it.

    • Enhanced Patient Engagement
      Genomic insights motivate patients to participate more actively in prevention, lifestyle change, and long-term care planning. Providers often see improved compliance and deeper trust.

    Contact us for more information on becoming a clinical partner.

The VitalRisk ™ assessment tool